Skip to main content
Caplight Logo









EndoCure

EndoCure

Private
IsraelHealthcare & Life Scienceshttps://endocure.tech/

Last Round

Seed

Jan 20, 2026

Total Funding Raised

$2.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

EndoCure is a medical device company that develops an AI-powered robotic ultrasound platform for the detection, mapping, and monitoring of endometriosis and other medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware + Subscription, Usage-Based SaaS

AI Layer

Application

Keywords

robotic ultrasoundmedical imagingfemtechmedtechmedical AIAI diagnostics3D ultrasoundendometriosis diagnosisdiagnostic imagingdigital healthAI-powered ultrasoundsurgical planningusage-based SaaSDICOMtelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EndoCure Comparables

Compare EndoCure with similar companies based on industry and business-model similarity.

EndoCure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scanvio Medical
83%
Cobionix Corporation
74%
ROPCA
72%

EndoCure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 20, 2026
Pre SeedNov 30, 2025

Key People

Founding team and executive leadership

Hadas Ziso

Founder, CEO

Founding Team

EndoCure Investors

Notable investors and investment history

EndoCure investors
InvestorRounds
Israel Innovation AuthorityPre Seed
Tech4EvaPre Seed
MassChallenge IsraelPre Seed
HiCenterPre Seed
TeuzaPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Completed a Seed funding round.

  • Jan 10, 2026

    Grew 25% QoQ, from 12 to 15 employees.

EndoCure Filings

Explore SEC and related filing metadata, where available.

EndoCure filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EndoCure's valuation, stock price, and market status.

Is EndoCure a public or private company?

EndoCure is a private company.

What is the current stock price of EndoCure?

EndoCure is a private company with no public stock price. No recent secondary market data is available.

How much is EndoCure worth (valuation)?

Valuation information for EndoCure is not publicly available.

Can I buy EndoCure stock?

EndoCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EndoCure's last funding round?

EndoCure's most recent funding round was Seed on January 20, 2026.

Who are the main investors in EndoCure?

Key investors in EndoCure include Teuza.

Will EndoCure IPO soon?

No public IPO plans have been announced for EndoCure.

How can I track EndoCure secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EndoCure's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range11
Year Founded2023
Last FundingJan 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?